FilingSEC EDGAR8-K
bioAffinity Technologies to Present on CyPath Lung at CHEST 2026
· SEC accepted
StageConference Presentation
Filing content
bioAffinity Technologies will sponsor a presentation at CHEST 2026 regarding the role of CyPath Lung in lung cancer risk stratification and pulmonary nodule management.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…